标题
Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies
作者
关键词
-
出版物
ONCOGENE
Volume 32, Issue 41, Pages 4861-4870
出版商
Springer Nature
发表日期
2013-01-14
DOI
10.1038/onc.2012.617
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma
- (2013) Vikram Deshpande et al. BMC CANCER
- Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer
- (2012) L. H. Jensen et al. ANNALS OF ONCOLOGY
- K-ras Mutation is Strongly Associated with Perineural Invasion and Represents an Independent Prognostic Factor of Intrahepatic Cholangiocarcinoma after Hepatectomy
- (2012) Tse-Ching Chen et al. ANNALS OF SURGICAL ONCOLOGY
- KrasG12D and p53 Mutation Cause Primary Intrahepatic Cholangiocarcinoma
- (2012) M. R. O'Dell et al. CANCER RESEARCH
- Down-regulation of miR-214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist
- (2012) Bin Li et al. FEBS Journal
- Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma
- (2012) Naoki Oishi et al. HEPATOLOGY
- Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma
- (2012) Benjamin R. Kipp et al. HUMAN PATHOLOGY
- Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract
- (2012) George Miller et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma
- (2012) William C. Palmer et al. JOURNAL OF HEPATOLOGY
- The microcosmos of cancer
- (2012) Amaia Lujambio et al. NATURE
- Exome sequencing of liver fluke–associated cholangiocarcinoma
- (2012) Choon Kiat Ong et al. NATURE GENETICS
- Ruxolitinib
- (2012) Ruben A. Mesa et al. NATURE REVIEWS DRUG DISCOVERY
- Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma
- (2011) M Miyamoto et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Antiangiogenic and Antimetastatic Activity of JAK Inhibitor AZD1480
- (2011) H. Xin et al. CANCER RESEARCH
- Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma
- (2011) Alphonse E Sirica et al. CURRENT OPINION IN GASTROENTEROLOGY
- A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational study
- (2011) Jun Ho Yi et al. EUROPEAN JOURNAL OF CANCER
- Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors
- (2011) Jesper B. Andersen et al. GASTROENTEROLOGY
- Development of molecularly targeted therapies in biliary tract cancers: Reassessing the challenges and opportunities
- (2011) Andrew X. Zhu et al. HEPATOLOGY
- Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER-medicare database
- (2011) Tania M. Welzel et al. HEPATOLOGY
- Myofibroblast-derived PDGF-BB promotes hedgehog survival signaling in cholangiocarcinoma cells
- (2011) Christian D. Fingas et al. HEPATOLOGY
- SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma
- (2011) Anthony B. El-Khoueiry et al. INVESTIGATIONAL NEW DRUGS
- Safety and Efficacy of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis
- (2011) Animesh Pardanani et al. JOURNAL OF CLINICAL ONCOLOGY
- Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers
- (2011) Tanios Bekaii-Saab et al. JOURNAL OF CLINICAL ONCOLOGY
- Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment
- (2011) Mechteld C. de Jong et al. JOURNAL OF CLINICAL ONCOLOGY
- Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells
- (2011) Hiroaki Sugiyama et al. JOURNAL OF GASTROENTEROLOGY
- Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study
- (2011) Jeeyun Lee et al. LANCET ONCOLOGY
- Deregulation of Hippo kinase signalling in Human hepatic malignancies
- (2011) Hua Li et al. LIVER INTERNATIONAL
- The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma
- (2011) Alphonse E. Sirica Nature Reviews Gastroenterology & Hepatology
- Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
- (2011) D. R. Borger et al. ONCOLOGIST
- Intrahepatic Cholangiocarcinoma: New Insights in Pathology
- (2011) Christine Sempoux et al. SEMINARS IN LIVER DISEASE
- Identification of a Cholangiocarcinoma-Like Gene Expression Trait in Hepatocellular Carcinoma
- (2010) H. G. Woo et al. CANCER RESEARCH
- Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma
- (2010) Horlad Hasita et al. CANCER SCIENCE
- Staging of intrahepatic cholangiocarcinoma
- (2010) Hari Nathan et al. CURRENT OPINION IN GASTROENTEROLOGY
- Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapy
- (2010) Zichen Zhang et al. HEPATOLOGY
- Genetics of Biliary Tract Cancers and Emerging Targeted Therapies
- (2010) Aram F. Hezel et al. JOURNAL OF CLINICAL ONCOLOGY
- Report of a Multicenter Phase II Trial Testing a Combination of Biweekly Bevacizumab and Daily Erlotinib in Patients With Unresectable Biliary Cancer: A Phase II Consortium Study
- (2010) Sam J. Lubner et al. JOURNAL OF CLINICAL ONCOLOGY
- Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study
- (2010) Birgit Gruenberger et al. LANCET ONCOLOGY
- Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
- (2010) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatic Stellate Cells May Relate to Progression of Intrahepatic Cholangiocarcinoma
- (2009) Hirohisa Okabe et al. ANNALS OF SURGICAL ONCOLOGY
- Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy
- (2009) Kawin Leelawat et al. BMC GASTROENTEROLOGY
- Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma
- (2009) D Yoshikawa et al. BRITISH JOURNAL OF CANCER
- Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial
- (2009) C Bengala et al. BRITISH JOURNAL OF CANCER
- The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
- (2009) Michael Hedvat et al. CANCER CELL
- A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer
- (2009) Ramesh K. Ramanathan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
- (2009) Y. Hoshida et al. CANCER RESEARCH
- Epidemiology of cholangiocarcinoma: An update focusing on risk factors
- (2009) Hai-Rim Shin et al. CANCER SCIENCE
- Intrahepatic Cholangiocarcinoma Progression: Prognostic Factors and Basic Mechanisms
- (2009) Alphonse E. Sirica et al. Clinical Gastroenterology and Hepatology
- MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3
- (2009) Florin M. Selaru et al. HEPATOLOGY
- Pattern of chromosomal aberrations in primary liver cancers identified by comparative genomic hybridization
- (2009) Kia Homayounfar et al. HUMAN PATHOLOGY
- Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas
- (2009) Nathalie Guedj et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study
- (2009) Andrew X Zhu et al. LANCET ONCOLOGY
- Clinical Significance of Cell Cycle–and Apoptosis-Related Markers in Biliary Tract Cancer
- (2008) Eva Karamitopoulou et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma
- (2008) D. Y. Chiang et al. CANCER RESEARCH
- EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
- (2008) Taro Yamashita et al. GASTROENTEROLOGY
- Pathobiology of biliary epithelia and cholangiocarcinoma: Proceedings of the Henry M. and Lillian Stratton basic research single-topic conference
- (2008) Alphonse E. Sirica et al. HEPATOLOGY
- Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment
- (2008) Boris Blechacz et al. HEPATOLOGY
- Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans
- (2008) Hashem B. El-Serag et al. HEPATOLOGY
- The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma
- (2008) Lei Chen et al. JOURNAL OF HEPATOLOGY
- Intrahepatic Cholangiocarcinoma: A Malignancy of Increasing Importance
- (2008) Chet W. Hammill et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Drug development of MET inhibitors: targeting oncogene addiction and expedience
- (2008) Paolo M. Comoglio et al. NATURE REVIEWS DRUG DISCOVERY
- Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma
- (2008) Alphonse E Sirica WORLD JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now